Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of nOPV2 Candidates in Adults
NCT04544787Phase 2Completed
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of nOPV2 candidate 1, novel oral poliovirus vaccine type 2 candidate 2 in poliomyelitis. Started Oct 2018; status: completed.
02
Drugs
nOPV2 candidate 1novel oral poliovirus vaccine type 2 candidate 2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04544787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04544787.